drugset / Trial / NCT02904759

Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects

NCT02904759

Phase 3 Completed 342 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to demonstrate efficacy of desmopressin ODT against placebo for the treatment of male subjects with nocturia due to nocturnal polyuria, during 12 weeks of treatment.

Timeline

Start
2016-09
Primary completion
2017-09-29
Completion
2017-09-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 25 ug
Subject Desmopressin Peptide 50 ug

Indications